Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An ovarian malignant germ cell tumor characterized by the presence of at least two different germ cell components. At least one of the germ cell components is primitive. The most common combination of germ cell elements is dysgerminoma and yolk sac tumor.
Biomarker and diagnostic research for ovarian mixed germ cell neoplasm has been reported in the published literature.
No clinical trials have been registered for ovarian mixed germ cell neoplasm.
46 publications have been identified in PubMed for ovarian mixed germ cell neoplasm. Research spans Case Report / Case Series (43%), Basic Science / Preclinical (20%), and Epidemiology / Natural History (13%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 20 | 43% |
Data assembled from 2 of 12 sources · Last updated Sep 20, 2026, 4:49 AM UTC
Laboratory research
9 |
20% |
Disease patterns and progression | 6 | 13% |
Research summaries | 5 | 11% |
Clinical study results | 3 | 7% |
Other research | 1 | 2% |
Testing and diagnosis research | 1 | 2% |
New treatment approaches | 1 | 2% |
Ren Y (2026). [PMID: 41474616](https://pubmed.ncbi.nlm.nih.gov/41474616/). *Cancer Med*. [Epidemiology / Natural History]
Fucina S (2026). [PMID: 41617447](https://pubmed.ncbi.nlm.nih.gov/41617447/). *Anticancer Res*. [Case Report / Case Series]
Ludmir D (2026). [PMID: 41448116](https://pubmed.ncbi.nlm.nih.gov/41448116/). *Gynecol Oncol*. [Case Report / Case Series]
Klar M (2026). [PMID: 41797204](https://pubmed.ncbi.nlm.nih.gov/41797204/). *J Surg Oncol*. [Clinical Trial Publication]
Ordoñez Arrillaga A (2026). [PMID: 41579581](https://pubmed.ncbi.nlm.nih.gov/41579581/). *Rev Esp Patol*. [Review / Meta-Analysis]
Abida PM (2026). [PMID: 41553048](https://pubmed.ncbi.nlm.nih.gov/41553048/). *Indian J Pathol Microbiol*. [Case Report / Case Series]
Imterat M (2026). [PMID: 41259847](https://pubmed.ncbi.nlm.nih.gov/41259847/). *Int J Gynecol Cancer*. [Case Report / Case Series]
Sadiq Q (2026). [PMID: 32644667](https://pubmed.ncbi.nlm.nih.gov/32644667/). *Unknown Journal*. [Basic Science / Preclinical]
Zanfagnin V (2026). [PMID: 41887253](https://pubmed.ncbi.nlm.nih.gov/41887253/). *Arch Pathol Lab Med*. [Basic Science / Preclinical]
Okiro P (2026). [PMID: 41617645](https://pubmed.ncbi.nlm.nih.gov/41617645/). *Pediatr Dev Pathol*. [Epidemiology / Natural History]